Inflammatory activation is increasingly recognized as a nonconventional risk factor for
arrhythmias, and experimental studies provided robust evidence that this association is …

Cirrhotic cardiomyopathy (CCM) is defined as systolic or diastolic dysfunction in the absence
of prior heart disease or another identifiable cause in patients with cirrhosis, in whom it is an …

Hepatic encephalopathy (HE) is a neurological complication of liver disease resulting in
cognitive, psychiatric, and motor symptoms. Although hyperammonemia is a key factor in the …

CCM is a clinically relevant syndrome affecting patients with cirrhosis, leading to increased
morbidity and mortality. New diagnostic criteria have been recently proposed by an expert …

Currently, living organisms are increasingly exposed to many toxic chemicals in the
environment. These substances pose a threat to human life, other living organisms and …

Aims To identify the cardiac biogenic amine profile of obese rats and associate these
compounds with parameters of cardiovascular disease. Main methods Wistar rats (n= 20) …

Myocardial dysfunction in end stage cirrhotic liver disease, termed cirrhotic cardiomyopathy,
is a long known, but little understood comorbidity seen in∼ 50% of adults and children who …

Cirrhotic patients often suffer from cirrhotic cardiomyopathy (CCM). Previous animal models
of CCM were inconsistent concerning the time and mechanism of injury; thus, the temporal …

Aims Liver cirrhosis is the main chronic liver disease and is considered a catabolic disease.
Cirrhotic patients have a low energy intake and high energy expenditure at rest, leading to …

Cirrhotic cardiomyopathy is a syndrome of blunted cardiac systolic and diastolic function in
patients with cirrhosis. However, the mechanisms remain incompletely known. Since …